Hannah Meiselman

I support HB1321 because elective IV therapy involves real medical risk and should be delivered under clear, enforceable safety standards. Consumers deserve assurance that anyone administering IV fluids is properly trained and supervised. This bill helps prevent avoidable harm while supporting responsible providers, and I urge the committee to ensure no loopholes weaken patient protections.